MGX News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-10 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-06-10 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 5.02,5.07. |
| 2026-05-11 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2026-03-05 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-01-12 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 5.03,7.01,9.01. |
| 2025-11-12 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2025-10-01 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 1.01,1.02. |
| 2025-08-12 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2025-06-11 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2025-05-14 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2025-05-13 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2025-03-17 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2025-03-17 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2025-01-16 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2024-12-10 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2024-11-13 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-09-03 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2024-08-14 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-05-14 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2024-05-01 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 1.02,2.02,7.01,9.01. |
| 2024-03-27 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-02-13 | Current report | SEC filing | Metagenomi Therapeutics, Inc. filed Form 8-K | Metagenomi Therapeutics, Inc. filed Form 8-K covering items 5.03,9.01. |